AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 83 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,958,000 | +44.2% | 301,864 | -1.0% | 1.08% | +47.5% |
| Q2 2021 | $2,052,000 | -16.8% | 304,922 | +11.8% | 0.73% | -30.9% |
| Q1 2021 | $2,467,000 | +324.6% | 272,845 | +213.9% | 1.06% | +301.1% |
| Q4 2020 | $581,000 | -55.3% | 86,916 | -45.2% | 0.26% | -49.1% |
| Q4 2017 | $1,300,000 | -21.9% | 158,555 | 0.0% | 0.52% | -27.4% |
| Q3 2017 | $1,665,000 | +19.4% | 158,555 | +25.4% | 0.71% | +22.3% |
| Q2 2017 | $1,395,000 | +44.7% | 126,463 | +27.0% | 0.58% | +25.4% |
| Q1 2017 | $964,000 | -6.9% | 99,587 | 0.0% | 0.46% | -10.9% |
| Q4 2016 | $1,035,000 | – | 99,587 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |